• Interaction Score: 4.73

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Evidence Type Actionable
    Approval Status Preclinical
    Response Type resistant

    PMIDs:
    26597303


    Sources:
    JAX-CKB

  • Interaction Score: 1.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Alteration CDH1:.
    Drug family AR inhibitor

    PMIDs:
    None found


    Sources:
    CGI

  • Interaction Score: 0.68

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Lapatinib + Capecitabine
    Indication/Tumor Type breast cancer
    Response Type sensitive

    PMIDs:
    26487584


    Sources:
    JAX-CKB

  • Interaction Score: 0.54

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Erlotinib + Selumetinib
    Indication/Tumor Type pancreatic ductal adenocarcinoma
    Response Type sensitive

    PMIDs:
    26251290


    Sources:
    JAX-CKB

  • Interaction Score: 0.53

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Lapatinib + Capecitabine
    Indication/Tumor Type breast cancer
    Response Type sensitive

    PMIDs:
    26487584


    Sources:
    JAX-CKB

  • Interaction Score: 0.36

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Erlotinib + Selumetinib
    Indication/Tumor Type pancreatic ductal adenocarcinoma
    Response Type sensitive

    PMIDs:
    26251290


    Sources:
    JAX-CKB